Acadia Healthcare (NASDAQ:ACHC) Downgraded to “Sell” Rating by StockNews.com

StockNews.com downgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research report released on Friday morning.

A number of other brokerages also recently commented on ACHC. Barclays decreased their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Royal Bank of Canada decreased their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. KeyCorp began coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft upped their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $79.67.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $39.99 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The stock has a 50 day moving average price of $53.36 and a two-hundred day moving average price of $64.32. The company has a market capitalization of $3.71 billion, a P/E ratio of 13.11, a PEG ratio of 1.69 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same quarter in the previous year, the company posted $0.91 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. Analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently modified their holdings of the business. GAMMA Investing LLC boosted its position in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after buying an additional 248 shares during the last quarter. Commonwealth Equity Services LLC boosted its position in shares of Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after buying an additional 257 shares during the last quarter. Atria Investments Inc boosted its position in shares of Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the last quarter. Finally, KBC Group NV boosted its position in shares of Acadia Healthcare by 14.4% during the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.